Emily Kelly, PhD

Microglia Act Differently in Male and Female Brains Microglia, the immune cells of the brain, exhibit sex-specific differences in response to the enzyme inhibitor PLX3397, which is commonly used in microglial research. While male microglia showed expected depletion after treatment, female microglia displayed increased survival through alternative signaling pathways. These findings challenge long-standing assumptions of uniform microglial behavior and could reshape research into neurodegenerative diseases like Alzheimer’s and Parkinson’s, where diagnosis rates differ by sex. Researchers emphasize the importance of sex-specific studies to better understand microglial activity under various conditions, including hormonal changes and inflammation. This discovery highlights the potential need for tailored therapeutic approaches targeting microglia based on sex. Further investigation is underway to explore the biological mechanisms behind these differences.